Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares surged 18.09 percent to close at $2.22 a share Monday. The stock traded between $2.15 and $2.59 on volume of 6.25 million shares traded. The company has announced that Pfizer “will expand commercialization of OXECTA (oxycodone HCl) Tablets CII to health care providers in the 4th quarter of 2013.”
Get more information on Acura Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/ACUR
Endologix, Inc. (NASDAQ: ELGX) shares spiked 5.42 percent to close at $14.00 a share Monday. The stock traded between $13.30 and $14.23 on volume of 831,777 shares traded. The company expects revenues for the second quarter of 2013 to be approximately $34.0 million, an increase of 33 percent year-over-year. Shares of Endologix are down approximately 1.7 percent year-to-date.
Get more information on Endologix and free access to the in-depth equity report at:
www.FiveStarEquities.com/ELGX
Insmed Inc. (NASDAQ: INSM) shares plunged 18.73 percent to close at $9.72 a share Monday. The stock traded between $9.00 and $10.65 on volume of 4.79 million shares traded. The company announced ARIKACE met its primary endpoint of non-inferiority to Novartis’ TOBI, but was not superior. Shares of Insmed have gained approximately 45.3 percent year-to-date.
Get more information on Insmed and free access to the in-depth equity report at:
www.FiveStarEquities.com/INSM
Twenty-First Century Fox Inc. (NASDAQ: NWSA) shares declined 5.13 percent to close at $14.79 a share Monday. The stock traded between $14.75 and $15.59 on volume of 25.82 million shares traded. On Friday, News Corp. separated into two companies: its publishing company, which is still to be named News Corp., and its movie and TV company, Twenty-First Century Fox Inc.
Get more information on Twenty-First Century Fox and free access to the in-depth equity report at:
www.FiveStarEquities.com/NWSA
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
info@fivestarequities.com